Cargando…
Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361977/ https://www.ncbi.nlm.nih.gov/pubmed/34114211 http://dx.doi.org/10.1111/bjh.17448 |
| _version_ | 1783738058744528896 |
|---|---|
| author | Moreau, Philippe Ghori, Razi Farooqui, Mohammed Marinello, Patricia San Miguel, Jesus |
| author_facet | Moreau, Philippe Ghori, Razi Farooqui, Mohammed Marinello, Patricia San Miguel, Jesus |
| author_sort | Moreau, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8361977 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83619772021-08-17 Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study Moreau, Philippe Ghori, Razi Farooqui, Mohammed Marinello, Patricia San Miguel, Jesus Br J Haematol Online Only John Wiley and Sons Inc. 2021-06-10 2021-07 /pmc/articles/PMC8361977/ /pubmed/34114211 http://dx.doi.org/10.1111/bjh.17448 Text en © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Online Only Moreau, Philippe Ghori, Razi Farooqui, Mohammed Marinello, Patricia San Miguel, Jesus Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title | Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title_full | Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title_fullStr | Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title_full_unstemmed | Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title_short | Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study |
| title_sort | pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: cohort 2 of the phase i keynote‐023 study |
| topic | Online Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361977/ https://www.ncbi.nlm.nih.gov/pubmed/34114211 http://dx.doi.org/10.1111/bjh.17448 |
| work_keys_str_mv | AT moreauphilippe pembrolizumabcombinedwithcarfilzomibandlowdosedexamethasoneforrelapsedorrefractorymultiplemyelomacohort2ofthephaseikeynote023study AT ghorirazi pembrolizumabcombinedwithcarfilzomibandlowdosedexamethasoneforrelapsedorrefractorymultiplemyelomacohort2ofthephaseikeynote023study AT farooquimohammed pembrolizumabcombinedwithcarfilzomibandlowdosedexamethasoneforrelapsedorrefractorymultiplemyelomacohort2ofthephaseikeynote023study AT marinellopatricia pembrolizumabcombinedwithcarfilzomibandlowdosedexamethasoneforrelapsedorrefractorymultiplemyelomacohort2ofthephaseikeynote023study AT sanmigueljesus pembrolizumabcombinedwithcarfilzomibandlowdosedexamethasoneforrelapsedorrefractorymultiplemyelomacohort2ofthephaseikeynote023study |